110 related articles for article (PubMed ID: 8866334)
1. Synergistic inhibition of human polymorphonuclear function by prostaglandin E1 and linsidomine.
Gladis-Villanueva M; Schrör K
J Pharm Pharmacol; 1996 Jul; 48(7):706-11. PubMed ID: 8866334
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of PGE1-induced increase in cyclic AMP by chemotactic peptide and Ca2+ ionophore through calmodulin-dependent processes.
Ishitoya J; Takenawa T
J Immunol; 1987 Feb; 138(4):1201-7. PubMed ID: 2433345
[TBL] [Abstract][Full Text] [Related]
3. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.
Schröder H; Ney P; Woditsch I; Schrör K
Eur J Pharmacol; 1990 Jul; 182(2):211-8. PubMed ID: 1697805
[TBL] [Abstract][Full Text] [Related]
4. cAMP and human neutrophil chemotaxis. Elevation of cAMP differentially affects chemotactic responsiveness.
Harvath L; Robbins JD; Russell AA; Seamon KB
J Immunol; 1991 Jan; 146(1):224-32. PubMed ID: 1701793
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils.
Talpain E; Armstrong RA; Coleman RA; Vardey CJ
Br J Pharmacol; 1995 Apr; 114(7):1459-65. PubMed ID: 7606349
[TBL] [Abstract][Full Text] [Related]
6. Involvement of cyclic AMP generation in the inhibition of respiratory burst by 2-phenyl-4-quinolone (YT-1) in rat neutrophils.
Wang JP; Raung SL; Huang LJ; Kuo SC
Biochem Pharmacol; 1998 Dec; 56(11):1505-14. PubMed ID: 9827585
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E1 inhibits N-formyl-methionyl-leucyl-phenylalanine-mediated depolarization responses by decreasing the proportion of responsive cells without affecting chemotaxin-induced forward light scatter changes.
Fletcher MP
J Immunol; 1987 Dec; 139(12):4167-73. PubMed ID: 3693900
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.
Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE
Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820
[TBL] [Abstract][Full Text] [Related]
9. Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors.
Burde R; Seifert R; Buschauer A; Schultz G
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):671-8. PubMed ID: 2559336
[TBL] [Abstract][Full Text] [Related]
10. Chemoattractant-elicited alterations of cAMP levels in human polymorphonuclear leukocytes require a Ca2+-dependent mechanism which is independent of transmembrane activation of adenylate cyclase.
Verghese MW; Fox K; McPhail LC; Snyderman R
J Biol Chem; 1985 Jun; 260(11):6769-75. PubMed ID: 2581959
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human neutrophil degranulation by forskolin in the presence of phosphodiesterase inhibitors.
Nourshargh S; Hoult JR
Eur J Pharmacol; 1986 Mar; 122(2):205-12. PubMed ID: 3011441
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic enzyme release and oxygen centered radical formation in human neutrophils are selectively inhibited by E-type prostaglandins but not by PGI2.
Hecker G; Ney P; Schrör K
Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):308-15. PubMed ID: 2159112
[TBL] [Abstract][Full Text] [Related]
13. Stimulus-dependent inhibition of superoxide generation by prostaglandins.
Sedgwick JB; Berube ML; Zurier RB
Clin Immunol Immunopathol; 1985 Feb; 34(2):205-15. PubMed ID: 2981649
[TBL] [Abstract][Full Text] [Related]
14. Peroxynitrite augments fMLP-stimulated chemiluminescence by neutrophils in human whole blood.
Bednar MM; Balazy M; Murphy M; Booth C; Fuller SP; Barton A; Bingham J; Golding L; Gross CE
J Leukoc Biol; 1996 Nov; 60(5):619-24. PubMed ID: 8929553
[TBL] [Abstract][Full Text] [Related]
15. Molsidomine inhibits the chemoattractant-induced respiratory burst in human neutrophils via a no-independent mechanism.
Ervens J; Seifert R
Biochem Pharmacol; 1992 Aug; 44(4):637-44. PubMed ID: 1324680
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human platelets and polymorphonuclear neutrophils by the potent and metabolically stable prostaglandin D2 analog ZK 118.182.
Darius H; Michael-Hepp J; Thierauch KH; Fisch A
Eur J Pharmacol; 1994 Jun; 258(3):207-13. PubMed ID: 7522176
[TBL] [Abstract][Full Text] [Related]
18. The blockade of formyl peptide-induced respiratory burst by 2',5'-dihydroxy-2-furfurylchalcone involves phospholipase D signaling in neutrophils.
Wang JP; Chang LC; Hsu MF; Lin CN
Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):166-74. PubMed ID: 12928764
[TBL] [Abstract][Full Text] [Related]
19. The effects of the nitric oxide donors molsidomine and SIN-I on human polymorphonuclear leucocyte function in vitro and ex vivo.
Darius H; Grodzinska L; Meyer J
Eur J Clin Pharmacol; 1992; 43(6):629-33. PubMed ID: 1337322
[TBL] [Abstract][Full Text] [Related]
20. Concentration-dependent regulatory effects of prostaglandin E1 on human neutrophil function in vitro.
Farmer JC; Burkey TH; Kew RR; Webster RO
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):593-9. PubMed ID: 1654039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
